The effect of Dexamethasone in the treatment of Septic Arthritis

Evaluation of addition of Dexamethason to Antibiothic treatment in case of Septic Arthritis

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190903044679N1

Enrollment

146

Registered

2019-12-19

Start date

2019-10-23

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pyogenic arthritis. Pyogenic arthritis

Interventions

Intervention group:Intervention group: 8mg Dexamethasone ampoule will be given every 4 hours for 4 days..

Eligibility

Sex/Gender

All

Age

12 Years to 90 Years

Inclusion criteria

Inclusion criteria: Age>12 and Age<90

Exclusion criteria

Exclusion criteria: HTN Poor control Diabet Melitius Recent history of Corticosteroid use Immunodeficiency RA Other Autoimmune Diseases that cause joint involvement

Design outcomes

Primary

Measure	Time frame
Duration of treatment. Timepoint: Daily. Method of measurement: Depending on the length of hospital stay.;The time it takes for CRP to normalize. Timepoint: Every three days. Method of measurement: Quantity.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmin Karampour

Qazvin University of Medical Sciences

a.karampour@qums.ac.ir+98 28 3333 9049

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026